Evidence map›Paper›PMID 39107314›Full record

ArticleNature communications2024

High-affinity agonism at the P2X

Adam C Oken, Nicolas E Lisi, Ipsita Krishnamurthy, Alanna E McCarthy, Michael H Godsey, Arthur Glasfeld, Steven E Mansoor

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Review
  2. Structural and molecular principles of DAMP biology.Nature structural & molecular biology · 2026
    Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Subtype-specific structural features of the hearing loss-associated human P2X2 receptor.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  15. Article
  16. Inter-Organellar CaCells · 2025
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Adam C OkenDepartment of Chemical Physiology & Biochemistry, Oregon Health & Science University, Portland, OR, 97239, USA.ORCID 0000-0002-8661-9888
Nicolas E LisiDepartment of Chemical Physiology & Biochemistry, Oregon Health & Science University, Portland, OR, 97239, USA.
Ipsita KrishnamurthyDepartment of Chemical Physiology & Biochemistry, Oregon Health & Science University, Portland, OR, 97239, USA.ORCID 0000-0003-3013-5689
Alanna E McCarthyDivision of Cardiovascular Medicine, Knight Cardiovascular Institute, Oregon Health & Science University, Portland, OR, 97239, USA.
Michael H GodseyDepartment of Chemical Physiology & Biochemistry, Oregon Health & Science University, Portland, OR, 97239, USA.ORCID 0000-0003-1006-7084
Arthur GlasfeldDepartment of Chemical Physiology & Biochemistry, Oregon Health & Science University, Portland, OR, 97239, USA.ORCID 0000-0003-0680-0263
Steven E MansoorDepartment of Chemical Physiology & Biochemistry, Oregon Health & Science University, Portland, OR, 97239, USA. mansoors@ohsu.edu.ORCID 0000-0001-9606-8955

Funding

Pacific Northwest Center for Cryo-EM - Screening supplementU24GM129547 · NIGMS · OREGON HEALTH & SCIENCE UNIVERSITY · PI EVANS, JAMES E, GOUAUX, JAMES E · 2018 to 2023
$54.8M
Program in Biomedical SciencesT32GM142619 · NIGMS · OREGON HEALTH & SCIENCE UNIVERSITY · PI Jeffrey Wallace Tyner · 2021 to 2026
$3.2M
Elucidation of P2X7 Receptor Signaling and Development of Novel Small Molecule and Aptamer Ligand TherapiesDP2GM149551 · NIGMS · OREGON HEALTH & SCIENCE UNIVERSITY · PI MANSOOR, STEVEN ELIAS · 2022 to 2025
$2.3M
Structure/Function Studies on the Mechanisms of Purinergic Receptor Activation and AntagonismR00HL138129 · NHLBI · OREGON HEALTH & SCIENCE UNIVERSITY · PI MANSOOR, STEVEN ELIAS · 2020 to 2022
$746k
American Heart Association (American Heart Association, Inc.) 24PRE1195450NHLBI NIH HHS R00 HL138129NIGMS NIH HHS DP2 GM149551NIGMS NIH HHS T32 GM142619NIGMS NIH HHS U24 GM129547U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI) R00HL138129U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) DP2GM149551
6 · The paper itself

Abstract

P2X receptors are trimeric ATP-gated ion channels that activate diverse signaling cascades. Due to its role in apoptotic pathways, selective activation of P2X

Indexed as

Adenosine TriphosphateCryoelectron MicroscopyReceptors, Purinergic P2X7AnimalsBinding SitesHEK293 CellsHumansModels, MolecularProtein BindingPurinergic P2X Receptor AgonistsRatsSodium3'-O-(4-benzoyl)benzoyladenosine 5'-triphosphateAdenosine TriphosphatePurinergic P2X Receptor AgonistsReceptors, Purinergic P2X7Sodium

Identifiers

PMID39107314
PMCPMC11303814

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.